ArticleCritical care (London, England)2025

Association between SGLT2 inhibitor use and risk of sepsis-induced cardiomyopathy in patients with type 2 diabetes: a propensity-matched cohort study.

Jheng-Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.